北信源(300352.SZ)擬與南京磊垚共設磊垚健康 投向健康產業的投資、股權投資及相關諮詢服務
格隆匯 12 月 18日丨北信源(300352.SZ)公佈,為進一步開拓業務領域,實現戰略規劃,公司與南京磊垚創業投資基金管理有限公司(“南京磊垚”)共同發起設立嘉興北信源磊垚健康產業投資合夥企業(有限合夥)(“磊垚健康”)。基金總規模為3000萬元,其中北信源作為有限合夥人(LP)以自有資金認繳出資2850萬元,認繳比例95%,剩餘資金由南京磊垚認繳。
嘉興北信源磊垚健康產業投資合夥企業(有限合夥)投資方向:健康產業的投資、股權投資及相關諮詢服務。
公司此次參與投資設立股權投資基金是在保證公司主營業務發展的前提下,藉助專業投資機構的行業資源、基金運作及專業投資管理經驗,及時把握投資機會,幫助公司獲取發展機會和新的利潤增長點,拓展產業戰略佈局,進一步提升公司的盈利能力和綜合競爭力,推動公司持續健康穩定發展。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.